Internal Medicine Alert – December 30, 2021
December 30, 2021
View Issues
-
Fluvoxamine Reduces the Risk for Hospitalization from COVID-19
Researchers found fluvoxamine (100 mg twice a day for 10 days) lowered the risk for hospitalization among high-risk outpatients diagnosed with COVID-19.
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
Reduce the Risk of Autoimmune Disease with Vitamin D, n-3 Fatty Acid Supplements
A randomized, controlled trial that included older adults showed vitamin D3 2,000 units daily or n-3 fatty acids 1,000 mg daily over five years reduced the incidence of autoimmune diseases 25% to 30%.
-
Importance of Age in the Application of Coronary Artery Calcium Detection
Using coronary CT strategy as a diagnostic first line in patients with symptoms suggestive of coronary artery obstruction revealed relying on the coronary calcium score alone is inadequate for younger patients with a higher frequency of non-calcified obstructions.
-
Intensive Monitoring for Asymptomatic Atrial Fibrillation Did Not Prevent Strokes
Screening with an implantable loop recorder resulted in dramatically higher rates of atrial fibrillation detection and ensuing anticoagulation, but without a significant decrease in risk of stroke or systemic embolism by six years of follow-up.
-
Pilocarpine Hydrochloride Ophthalmic Solution 1.25% (Vuity)
Pilocarpine ophthalmic solution (OS) can be prescribed to treat presbyopia.